Herantis Pharma Oyj Sustainability Reports

Herantis Pharma Oyj focuses on developing innovative therapies for neurodegenerative and lymphatic diseases.

Sector: Health Care

Country: Finland

Exchange: Nasdaq Helsinki

ISIN: FI4000087861

8 reports from 2016 to 2025

Company Profile

Herantis Pharma Oyj

Herantis Pharma Oyj focuses on developing innovative therapies for neurodegenerative and lymphatic diseases.

MIC

 

Ticker

 

ISIN

 

Website

www.herantis.com

Country

Finland

Exchange

Nasdaq Helsinki

Sector

Health Care

Industry

Pharmaceuticals, Biotechnology & Life Sciences

Reports

Available reports